March 5 2025 - Jazz hands over $935M to buy Chimerix for near-approval cancer drug

Jazz hands over $935M to buy Chimerix for near-approval cancer drug
Kenvue settles proxy fight with activist Starboard, appoints three directors
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
DOGE claims $30M savings from canceling 30 FDA leases
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud